Quantcast
Last updated on April 17, 2014 at 11:05 EDT

Elsevier Offers Free Access to ScienceDirect to Early Career Researchers Impacted by an Uncertain Job Market

November 13, 2012

AMSTERDAM, November 13, 2012 /PRNewswire/ –

– A new program aims to help postdocs stay current in their field

Elsevier [http://www.elsevier.com/wps/find/homepage.cws_home ], a world-leading
provider of scientific, technical and medical information products and services, today
announced the launch of the Postdoc Free Access Program, a new initiative designed to help
early career researchers who are in between research positions stay up-to-date in their
field.

For scholars who have recently received their PhD and currently do not have a research
position, the program will offer postdocs a Free Access Passport, with complimentary
access to journals and books on ScienceDirect for up to 6 months.

The global economic climate for science funding has created new challenges for post
doctoral students, especially for those looking for employment. In response to this
growing trend, the program was conceived by editors and publishers at Elsevier who began
to hear from postdocs in countries where funding has been hit hardest. Many emphasized the
mounting pressure to stay competitive and publish, in many cases without the resources to
do so.

Lenka Stockova, a research assistant from the Czech Republic said about the
initiative, “This is a great opportunity for postdocs to keep in touch with the latest
news in their field of interest and to identify the most active centers of research where
they can apply for a position.” According to Lenka, access to published research is “not
only important, it is really necessary. Otherwise you cannot keep up with the latest
research in your branch of study.”

Professor Stephen Neidle, Editor-in-Chief of Bioorganic & Medicinal Chemistry, part of
Elsevier’s flagship Tetrahedron chemistry journal portfolio, who was part of the team that
devised the program, explains, “Postdocs are facing a challenging time as big pharma has
closed down many operations in Europe and the United States. University budgets are
squeezed and research budgets are reduced. It will be important to keep the interest and
commitment of the younger generation.”

In order to qualify for the Free Access Passport, candidates will be asked to fill out
a form verifying their credentials, before December 15, 2012. Once approved, they will
receive a personal code allowing access to ScienceDirect.

Qualifying criteria include:

        - Postdoc researchers who have received their PhD within the past 10 years
        - At least one recent postdoc position which was completed in the past three
          months or that will be completed within three months
        - A letter of recommendation from the postdoc's supervisor and/or institution
          verifying employment

For Alicia Wise, Elsevier’s Director of Universal Access, the program provides an
opportunity to invest in the future of science by keeping promising young scientists–who
would otherwise be without access to content–current in their field. “Postdocs today face
a multitude of challenges, between an uncertain job market and the inherent temporary
nature of research projects themselves,” she said. “At Elsevier, we know that access to
published research is vital for early career researchers to stay connected, to stay
competitive, and to get that next project or job.”

More information about the program and the application form can be accessed at

http://www.elsevier.com/postdocfreeaccess

About ScienceDirect

ScienceDirect [http://www.sciencedirect.com ] contains over a quarter of the world’s
full text scientific, technical and medical (STM) peer-reviewed articles – managed by
renowned editors, written by respected authors and read by researchers from around the
globe. Elsevier’s extensive full-text collection covers authoritative titles from the core
scientific literature with more than ten million articles available online. Coverage
includes over 2,500 journal titles published by Elsevier with dynamic linking to journals
from approximately 2,000 STM publishers through CrossRef. Additionally, SciVerse
ScienceDirect contains an expanding library of online major reference works, handbooks,
book series and over 10,000 eBooks in all fields of science seamlessly interlinked with
primary research referenced in journal articles.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Tom Reller
        Vice President, Global Corporate Relations
        +1-215-239-3508
        T.Reller@Elsevier.com

SOURCE Elsevier


Source: PR Newswire